During this event, Dr Serafeim Pousias, Consultant Obstetrician & Gynaecologist, and Dr Sofia-Paraskevi Trachana, Consultant Obstetrician & Gynaecologist at MYFERTILITY, broke down everything you needed to know about PGT-A (Preimplantation Genetic Testing for Aneuploidy) and its role in egg donation cycles.
Dr Pousias and Dr Trachana discussed the science, benefits, and limitations of PGT-A, explaining what it is, how it works, when it’s recommended during egg donation cycles, and whether it can help increase success rates. Preimplantation genetic testing for aneuploidy (PGT-A) and egg donation are two of the most discussed and sometimes controversial topics in modern fertility treatment.
In this event, Dr Serafeim Pousias and Dr Sofia-Paraskevi Trachana explained how PGT-A and egg donation work, when they are indicated, what patients can realistically expect, and how these treatments are regulated in Greece.
What is PGT-A, and why is it used?
Dr Pousias began by explaining that PGT-A, or preimplantation genetic testing for aneuploidy, is a genetic analysis performed on embryos created through IVF. Its purpose is to assess whether an embryo has the correct number of chromosomes.
A chromosomally normal embryo, known as euploid, contains 46 chromosomes. Embryos with too many or too few chromosomes are considered aneuploid. Aneuploidy is the most common cause of implantation failure and miscarriage, particularly as maternal age increases.
PGT-A is used to:
-
identify embryos with the correct chromosomal number
-
reduce the risk of miscarriage
-
improve IVF outcomes
-
lower the likelihood of transferring embryos with chromosomal abnormalities
Types of preimplantation genetic testing
Dr Pousias clarified that PGT-A is one of several types of preimplantation genetic testing:
-
PGT-A: screening for chromosomal aneuploidy
-
PGT-M: testing for specific monogenic (single-gene) diseases when parents are carriers
-
PGT-SR: testing for structural chromosomal rearrangements
Each type addresses a different clinical indication, and the choice depends on the couple’s medical and genetic background.
How PGT-A is performed during IVF
The procedure follows standard IVF steps. Ovarian stimulation is carried out, eggs are retrieved and fertilised, and embryos are cultured in the laboratory. On day five or six, when embryos reach the blastocyst stage, a biopsy is performed.
A small number of cells are taken from the trophoblast, the part of the embryo that will later form the placenta. These cells are sent to a genetic laboratory for analysis. Based on the results, embryos are classified as chromosomally normal or abnormal.
Only embryos identified as euploid are selected for transfer. According to Dr Pousias, the cumulative success rate after three single euploid embryo transfers can reach close to 60%.
Benefits and limitations of PGT-A
PGT-A offers several benefits:
-
improved selection of embryos for transfer
-
reduced miscarriage risk
-
lower chance of chromosomal disease
-
increased cumulative pregnancy rates
However, Dr Pousias emphasised that PGT-A does not guarantee pregnancy. Not all genetic conditions can be detected, and implantation still depends on multiple factors, including uterine receptivity and overall health.
He also stressed the importance of prenatal testing during pregnancy, even after PGT-A, to confirm fetal health.
Legal indications for PGT-A in Greece
Greek legislation strictly regulates the use of PGT-A. According to Dr Pousias, PGT-A is permitted when:
-
a woman is aged 40 or older
-
a couple has experienced two or more first-trimester miscarriages
-
there have been three or more failed IVF cycles
-
one partner has a pathological karyotype or structural chromosomal abnormality
PGT-M is allowed when parents are carriers of monogenic diseases such as cystic fibrosis, beta-thalassaemia, fragile X syndrome, or haemophilia. In rare cases, PGT may also be used to select an embryo that is a compatible donor for a sibling requiring stem cell or bone marrow transplantation.
What is egg donation?
Dr Trachana explained that egg donation is a fertility option for women who cannot conceive using their own eggs. Although the genetic material comes from a donor, the recipient carries the pregnancy and gives birth.
Egg donation may be considered for:
-
women with very poor egg quality
-
women without ovaries but with a healthy uterus
-
women with serious genetic conditions, they do not wish to pass on
-
women with repeated failed IVF cycles using their own eggs
-
women of advanced reproductive age, often over 45
In clinical practice, egg donation is usually discussed after multiple unsuccessful embryo transfers with the patient’s own eggs.
Egg donor requirements and screening
Egg donors in Greece must meet strict legal and medical criteria. According to the law, donors must be healthy women between 21 and 31 years old.
Donors undergo extensive screening, including:
-
full medical and family history
-
psychological assessment
-
ovarian reserve evaluation
-
genetic testing such as karyotype analysis, cystic fibrosis screening, fragile X testing, and spinal muscular atrophy screening
These requirements are defined by national legislation to ensure safety for both the recipient and child.
The egg donation process step by step
The donor undergoes ovarian stimulation, similar to a standard IVF cycle. Once the eggs are mature, they are retrieved and fertilised in the laboratory using either the recipient’s partner’s sperm or donor sperm.
The resulting embryos are transferred into the recipient’s uterus after appropriate endometrial preparation. Fertilisation and embryo transfer take place in Greece.
Anonymity and donor selection in Greece
Dr Trachana explained that egg donation in Greece is fully anonymous. Neither donor nor recipient can know the other’s identity. The only exception involves very close relatives, such as sisters, and even then, special permission is required from the Hellenic Authority of Human Reproduction, particularly if the donor is over 35.
At MYFERTILITY, donor selection is performed by the medical team based on the recipient’s physical characteristics and medical needs. Recipients do not have access to donor photos, names, or personal background details. Only medical screening results are shared with the doctor.
The clinic also collaborates with international egg banks, where recipients may choose donors themselves. In these cases, donor photos may be available, but identity remains protected.
Age limits and legal framework in Greece
Under Greek law, women aged 50 to 54 require special approval from the Hellenic Authority of Human Reproduction to undergo fertility treatment. The upper age limit for any fertility treatment in Greece is 54 years.
Success rates with egg donation
Egg donation offers high success rates compared to IVF with own eggs in older patients. Dr Trachana stated that pregnancy rates with donor eggs range from 60% to 65%.
She emphasised that success is influenced by:
While success rates are high, they are not 100%, and realistic expectations are essential.
Key take-home messages
Dr Pousias and Dr Trachana concluded with several important points:
-
PGT-A is a powerful tool for improving embryo selection, butit it does not guarantee pregnancy
-
Genetic counselling is essential before and after testing
-
Egg donation allows women without viable eggs to experience pregnancy and childbirth
-
Greek legislation ensures strict regulation, safety, and donor anonymity
-
With appropriate medical guidance, both PGT-A and egg donation can significantly improve fertility outcomes
It is estimated that more than one million children worldwide are born each year using donor eggs. As the speakers noted, for some patients, this path may offer the best opportunity to achieve a healthy pregnancy and baby.